Celularity Inc.

Celularity Inc.verified

CELU

Price:

$2.76

Market Cap:

$60.68M

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic ...[Read more]

Industry

Biotechnology

IPO Date

2019-08-08

Stock Exchange

NASDAQ

Ticker

CELU

The Enterprise Value as of November 2024 (TTM) for Celularity Inc. (CELU) is 91.81M

According to Celularity Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 91.81M. This represents a change of -20.82% compared to the average of 115.96M of the last 4 quarters.

Celularity Inc. (CELU) Historical Enterprise Value (quarterly & annually)

How has CELU Enterprise Value performed in the past?

The mean historical Enterprise Value of Celularity Inc. over the last ten years is 961.50M. The current 91.81M Enterprise Value has changed 854.85% with respect to the historical average. Over the past ten years (40 quarters), CELU's Enterprise Value was at its highest in in the June 2021 quarter at 1.25B. The Enterprise Value was at its lowest in in the June 2024 quarter at 100.83M.

Quarterly (TTM)
Annual

Average

961.50M

Median

447.97M

Minimum

109.19M

Maximum

3.52B

Celularity Inc. (CELU) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Celularity Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 272.85%

Maximum Annual Enterprise Value = 3.52B

Minimum Annual Increase = -92.48%

Minimum Annual Enterprise Value = 109.19M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023109.19M-57.19%
2022255.04M-59.60%
2021631.26M-36.03%
2020986.85M272.85%
2019264.68M-92.48%

Celularity Inc. (CELU) Average Enterprise Value

How has CELU Enterprise Value performed in the past?

The current Enterprise Value of Celularity Inc. (CELU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

331.83M

5-year avg

449.40M

10-year avg

961.50M

Celularity Inc. (CELU) Enterprise Value vs. Peers

How is CELU’s Enterprise Value compared to its peers?

Celularity Inc.’s Enterprise Value is greater than Immix Biopharma, Inc. (30.53M), greater than ZyVersa Therapeutics, Inc. (2.53M), greater than Hepion Pharmaceuticals, Inc. (5.35M), greater than AVROBIO, Inc. (-85302404.00), greater than eFFECTOR Therapeutics, Inc. (4.74M), greater than CNS Pharmaceuticals, Inc. (209.41K), less than VectivBio Holding AG (848.58M), less than Navidea Biopharmaceuticals, Inc. (0), greater than Sonnet BioTherapeutics Holdings, Inc. (-2504975.00), greater than null (-907921.00),

Build a custom stock screener for Celularity Inc. (CELU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celularity Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celularity Inc. (CELU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celularity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Celularity Inc.'s Enterprise Value?

What is the highest Enterprise Value for Celularity Inc. (CELU)?

What is the 3-year average Enterprise Value for Celularity Inc. (CELU)?

What is the 5-year average Enterprise Value for Celularity Inc. (CELU)?

How does the current Enterprise Value for Celularity Inc. (CELU) compare to its historical average?